Shared Decision Making for Patients With First-admission Schizophrenia: a Randomized Controlled Trial

Yokohama City University1 site in 1 country23 target enrollmentJune 2013

ConditionsSchizophrenia

Overview

Phase: Phase 2
Intervention: Not specified
Conditions: Schizophrenia
Sponsor: Yokohama City University
Enrollment: 23
Locations: 1
Primary Endpoint: Patient satisfaction as measured by the Japanese version of the Client Satisfaction Questionnaire (CSQ-8)
Status: Completed
Last Updated: 10 years ago

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

To determine whether shared decision making (SDM) intervention improves patient satisfaction in patients with first-admission schizophrenia compared with usual care.

Registry

clinicaltrials.gov

Start Date

June 2013

End Date

October 2015

Last Updated

10 years ago

Study Type

Interventional

Study Design

Parallel

Sex

All

Investigators

Sponsor

Yokohama City University

Responsible Party

Sponsor

Eligibility Criteria

Inclusion Criteria

•Admitted to an acute care psychiatric ward.
•Diagnosed with schizophrenia (ICD-10 codes: F20-F29)
•Aged 16 to 65 years old at admission
•No prior experience of psychiatric admission (first-admission)

Exclusion Criteria

•Diagnosed with moderate to severe mental retardation
•Diagnosed with organic mental disorders (ICD10 codes: F00-F09)
•Having poor Japanese language skill
•Severe conceptual disorganization as measured by brief psychiatric rating scale of 5 or more.

Outcomes

Primary Outcomes

Patient satisfaction as measured by the Japanese version of the Client Satisfaction Questionnaire (CSQ-8)

Time Frame: Within 7days before the date of discharge

Secondary Outcomes

Attitude toward medication as measured by the Japanese version of the Drug Attitude Inventory (DAI-10)(Within 7days before the date of discharge)
Treatment continuation as measured by the rate of outpatient attendance during the 30 days(6 months after discharge)